11/14/2024
3:50 PM | Inhibrx (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
06/10/2024
4:10 PM | Inhibrx (Filer)
| Form 15-12G | |
06/03/2024
4:55 PM | HALVORSEN OLE ANDREAS (Reporting)
Inhibrx (Issuer)
Ott David C. (Reporting)
Shabet Rose Sharon (Reporting)
VIKING GLOBAL INVESTORS LP (Reporting)
Viking Global Opportunities GP LLC (Reporting)
Viking Global Opportunities Illiquid Investments Sub-Master LP (Reporting)
Viking Global Opportunities Parent GP LLC (Reporting)
Viking Global Opportunities Portfolio GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
4:56 PM | Inhibrx (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G/A | |
05/31/2024
3:30 PM | Inhibrx Biosciences, Inc. (Issuer)
Inhibrx (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
5:22 PM | Inhibrx (Issuer)
Lappe Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
5:23 PM | Inhibrx (Issuer)
MANHARD KIMBERLY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/30/2024
5:23 PM | Inhibrx (Issuer)
Vuori Kristiina MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
5:21 PM | Deck Kelly (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
5:21 PM | Eckelman Brendan P. (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
5:22 PM | FORSYTH DOUGLAS (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
5:22 PM | Inhibrx (Issuer)
Kayyem Jon Faiz (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
3:32 PM | Inhibrx (Filer)
| Form POSASR | |
05/30/2024
3:33 PM | Inhibrx (Filer)
| Form S-8 POS | |
05/30/2024
3:33 PM | Inhibrx (Filer)
| Form S-8 POS | |
05/30/2024
3:34 PM | Inhibrx (Filer)
| Form S-8 POS | |
05/30/2024
3:34 PM | Inhibrx (Filer)
| Form S-8 POS | |
05/30/2024
7:39 AM | Inhibrx (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
05/28/2024
3:55 PM | Eckelman Brendan P. (Reporting)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024
5:15 PM | Eckelman Brendan P. (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
3:44 PM | Inhibrx Biosciences, Inc. (Issuer)
Inhibrx (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/22/2024
8:54 AM | Eckelman Brendan P. (Reporting)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024
8:48 PM | Inhibrx (Filer)
| Form DEFA14A | |
05/17/2024
4:29 PM | Inhibrx (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:08 PM | Inhibrx (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
3:42 PM | Inhibrx (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:36 PM | Deck Kelly (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
3:22 PM | Deck Kelly (Reporting)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/22/2024
3:54 PM | Deck Kelly (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
2:56 PM | Deck Kelly (Reporting)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/21/2024
3:36 PM | Deck Kelly (Reporting)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
3:50 PM | Deck Kelly (Reporting)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
3:46 PM | Deck Kelly (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:48 PM | Eckelman Brendan P. (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:22 PM | Deck Kelly (Reporting)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024
10:34 AM | Eckelman Brendan P. (Reporting)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024
5:04 PM | Eckelman Brendan P. (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
3:20 PM | Deck Kelly (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
2:28 PM | Deck Kelly (Reporting)
Inhibrx (Subject)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
3:41 PM | Deck Kelly (Reporting)
Inhibrx (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
1:58 PM | Deck Kelly (Reporting)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
We recommended Palantir in 2021, now we’re recommending this... (Ad) My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol |
03/04/2024
5:26 PM | Deck Kelly (Reporting)
Inhibrx (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
4:26 PM | Inhibrx (Filer)
| Form PREM14A | |
02/28/2024
8:10 AM | Inhibrx (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2024
8:12 AM | Inhibrx (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2024
3:30 PM | Inhibrx (Filer)
| Form DEFA14A | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Inhibrx (Subject)
| Form SC 13G/A | |
01/23/2024
4:25 PM | Inhibrx (Filer)
| Form DEFA14A | |
01/23/2024
9:10 AM | Inhibrx (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/23/2024
5:35 AM | Inhibrx (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2024
5:38 AM | Inhibrx (Filer)
| Form DEFA14A | |
